Tenet Healthcare (THC): Sutaria files 50,000-share resale notice
Rhea-AI Filing Summary
TENET HEALTHCARE CORP (THC) received a notice under Rule 144 for a proposed resale of its common stock for the account of Saumya S. Sutaria through Fidelity Brokerage Services LLC. The notice covers up to 50,000 shares of common stock with an aggregate market value of $13,935,240.26, with an approximate sale date of August 24, 2026. Shares of common stock outstanding were 80,519,000 at the time referenced, which is a baseline figure, not the amount being sold. The securities to be sold were acquired as compensation through restricted stock vesting on three dates in early 2025.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 50,000 shares
Aggregate market value: $13,935,240.26
Shares outstanding: 80,519,000 shares
+4 more
7 metrics
Shares to be sold
50,000 shares
Common stock proposed to be sold under Rule 144
Aggregate market value
$13,935,240.26
Value of 50,000 shares of common stock covered by the notice
Shares outstanding
80,519,000 shares
Common shares outstanding as referenced in the notice
Approximate sale date
08/24/2026
Planned sale timing for the covered shares
Restricted stock vesting 1
22,276 shares
Compensation shares vesting on 02/23/2025
Restricted stock vesting 2
10,569 shares
Compensation shares vesting on 02/28/2025
Restricted stock vesting 3
17,155 shares
Compensation shares vesting on 03/01/2025
Key Terms
Rule 144, restricted stock vesting, aggregate market value, attorney-in-fact
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 02/23/2025 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
aggregate market value financial
"50000 | 13935240.26 | 80519000 | 08/24/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
attorney-in-fact regulatory
"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
What does the Form 144 filed for THC disclose?
It discloses a proposed resale under Rule 144 of up to 50,000 shares of TENET HEALTHCARE CORP common stock for the account of Saumya S. Sutaria, to be executed through Fidelity Brokerage Services LLC, with an approximate sale date of August 24, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.